Главная Назад


Авторизация
Идентификатор пользователя / читателя
Пароль (для удалённых пользователей)
 

Вид поиска

Область поиска
в найденном
Найдено в других БД
Формат представления найденных документов:
библиографическое описание краткийполный
Отсортировать найденные документы по:
авторузаглавиюгоду изданиятипу документа
Поисковый запрос: (<.>S=НЕНУКЛЕОЗИДНЫЕ ИНГИБИТОРЫ<.>)
Общее количество найденных документов : 53
Показаны документы с 1 по 20
 1-20    21-40   41-53 
1.
Uckun Fatih M. NNI for treatment of multi-drug resistant HIV

2.
Uckun Fatih M. NNI for treatment of multi-drug resistant HIV

3.
Brown Jodian A. Dual allosteric inhibitors jointly modulate structure and dynamics in the Hepatitis C Virus polymerase // J. Biomol. Struct. and Dyn., 2015. Vol. 33, прил..-С.116-117

4.
Дизайн новых производных урацила, обладающих ингибиторной активностью в отношении обратной транскриптазы мутанта K103N/Y181C ВИЧ-1 // Хим.-фармац. ж., 2015. Т. 49, N 10.-С.40-43

5.
Бабков Д.А. СИНТЕЗ 3-[2-(2-БЕНЗОИЛФЕНОКСИ)ЭТИЛ]-1-[2-(ФЕНОКСИ)ЭТИЛ]ПРОИЗВОДНЫХ УРАЦИЛА КАК ПОТЕНЦИАЛЬНЫХ АНТИ-ВИЧ-1 АГЕНТОВ // Фундам. исслед., 2014, N 9.-С.2440-2445

6.
Genotypic and phenotypic analyses of heptitis C virus from patients treated with JTK-853 in a three-day monotherapy // Antimicrob. Agents and Chemother., 2013. Vol. 57, N 1.-С.436-444

7.
Effect of mutations at position E138 in HIV-1 reverse transcriptase and their interactions with the M184I mutation on defining patterns of resistance to nonnucleoside reverse transcriptase inhibitors rilpivirine and etravirine // Antimicrob. Agents and Chemother., 2013. Vol. 57, N 7.-С.3100-3109

8.
Genotypic and phenotypic analyses of heptitis C virus from patients treated with JTK-853 in a three-day monotherapy // Antimicrob. Agents and Chemother., 2013. Vol. 57, N 1.-С.436-444

9.
Взаимосвязь между наличием малых мутаций устойчивости к ненуклеозидным ингибиторам обратной транскриптазы, приверженностью к лечению и риском вирусологической неудачи // AIDS, 2012. Т. 5, N 1.-С.57

10.
Caillet-Saguy An objective assessment of conformational variability in complexes of hepatitis C virus polymerase with non-nucleoside inhibitors // J. Mol. Biol., 2011. Vol. 414, N 3.-С.370-384

11.
Phase 2a randomized controlled trial of short-term activity, safety, and pharmacokinetics of a novel nonnucleoside reverse transcriptase inhibitor, RDEA806, in HIV-1-positive, antiretroviral-naive subjects // Antimicrob. Agents and Chemother., 2010. Vol. 54, N 8.-С.3170-3178

12.
Phase 2a randomized controlled trial of short-term activity, safety, and pharmacokinetics of a novel nonnucleoside reverse transcriptase inhibitor, RDEA806, in HIV-1-positive, antiretroviral-naive subjects // Antimicrob. Agents and Chemother., 2010. Vol. 54, N 8.-С.3170-3178

13.
The disposition and metabolism of GW695634: A non-nucleoside reverse transcriptase inhibitor (NNRTi) for treatment of HIV/AIDS // Xenobiotica, 2010. Vol. 40, N 6.-С.437-445

14.
Phase 2a randomized controlled trial of short-term activity, safety, and pharmacokinetics of a novel nonnucleoside reverse transcriptase inhibitor, RDEA806, in HIV-1-positive, antiretroviral-naive subjects // Antimicrob. Agents and Chemother., 2010. Vol. 54, N 8.-С.3170-3178

15.
A novel nonnucleoside analogue that inhibits human immunodeficiency virus type 1 isolates resistant to current nonnucleoside reverse transcriptase inhibitors // Antimicrob. Agents and Chemother., 2007. Vol. 51, N 2.-С.429-437

16.
Hepatitis C virus (HCV) NS5B nonnucleoside inhibitors specifically block single-stranded viral RNA synthesis catalyzed by HCV replication complexes in vitro // Antimicrob. Agents and Chemother., 2007. Vol. 51, N 1.-С.338-342

17.
A novel nonnucleoside analogue that inhibits human immunodeficiency virus type 1 isolates resistant to current nonnucleoside reverse transcriptase inhibitors // Antimicrob. Agents and Chemother., 2007. Vol. 51, N 2.-С.429-437

18.
A novel nonnucleoside analogue that inhibits human immunodeficiency virus type 1 isolates resistant to current nonnucleoside reverse transcriptase inhibitors // Antimicrob. Agents and Chemother., 2007. Vol. 51, N 2.-С.429-437

19.
Synthesis and anti-HIV-1 activity evaluation of 5-alkyl-2-alkylthio-6-(arylcarbonyl or 'альфа'-cyanoarylmethyl)-3,4-dihydropyrimidin-4(3H)-ones as novel non-nucleoside HIV-1 reverse transcriptase inhibitors // J. Med. Chem., 2007. Vol. 50, N 8.-С.1778-1786

20.
Hepatitis C virus (HCV) NS5B nonnucleoside inhibitors specifically block single-stranded viral RNA synthesis catalyzed by HCV replication complexes in vitro // Antimicrob. Agents and Chemother., 2007. Vol. 51, N 1.-С.338-342

 1-20    21-40   41-53 
 




© Международная Ассоциация пользователей и разработчиков электронных библиотек и новых информационных технологий
(Ассоциация ЭБНИТ)